AAMA releases updated specification for anodized aluminum

AAMA 611-12 describes test procedures and requirements for high performance (Class I) and commercial (Class II) architectural quality aluminum oxide coatings applied to aluminum extrusions and panels for architectural products.

By By BD+C Staff | April 23, 2012

AMA 611-12, "Voluntary Specification for Anodized Architectural Aluminum" has been published by the American Architectural Manufacturers Association (AAMA). AAMA 611-12 describes test procedures and requirements for high performance (Class I) and commercial (Class II) architectural quality aluminum oxide coatings applied to aluminum extrusions and panels for architectural products. The specification also covers anodized finishes produced in batch or continuous coil.

"Updated from the 1998 version, AAMA 611-12 includes clarification of visual inspection language regarding surface imperfections and addition of coating observation and angle inspection," says Andy Joswiak (Apogee Enterprises, Inc./Linetec), chair of the AAMA Anodic Finishes (AAMA 611) Task Group. "Also, the updated specification contains additions and clarifications of finishes to the applicable Aluminum Association Designation System for Aluminum Finishes for pretreatments and finishes."

AAMA 611-12 references important industry standards which include AAMA 609 and 610-09, "Cleaning and Maintenance Guide for Architecturally Finished Aluminum," AAMA 800-10, "Voluntary Specifications and Test Methods for Sealants" and ASTM B137-95 (2009), "Standard Test Method for Measurement of Coating Mass per Unit Area on Anodically Coated Aluminum."

AAMA 611-12, "Voluntary Specification for Anodized Architectural Aluminum" is available for AAMA members to download at a cost of $10. Non-members may purchase the document at a cost of $30 for download. The specification is also available for purchase on CD and hardcopy. To order AAMA 611-12, visit AAMA's Publication Store. BD+C

In its 2021 Life Sciences Real Estate Outlook, JLL predicted that access to talent would be a primary concern for an industry sector that had been growing by leaps and bounds. A year later, talent still guides real estate decisions. But market conditions of a different sort were cooling the biotech field: namely, investors that have soured on startups which underperformed after going public. What this means for new construction and renovation going forward is unpredictable, as the drivers behind life sciences’ surge are still palpable.